Pharmacotherapy for alcohol use disorder: current and emerging therapies

Abstract

Alcohol use disorder is a heterogeneous illness with a complex biology that is controlled by many genes and gene-by-environment interactions. Several efficacious, evidence-based treatments currently exist for treating and managing alcohol use disorder, including a number of pharmacotherapies that target specific aspects of biology that initiate and maintain dangerous alcohol misuse. This article reviews the neurobiological and neurobehavioral foundation of alcohol use disorder, the mechanisms of action and evidence for the efficacy of currently approved medications for treatment, and the literature on other emerging pharmacotherapies.

Conflict of interest statement

Declaration of interest: Dr. Swift is a member of an advisory board for D&A Pharma and has received honoraria and travel reimbursements from the company. He has received research funding, consulting fees, and travel reimbursement from Farmaceutico CT, and honoraria and travel reimbursements from Lundbeck.